News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hikma Pharmaceuticals Agrees to Acquire Alkan Pharma for $60.5 Million


8/9/2007 7:53:35 AM

LONDON, 9 August 2007 – Hikma Pharmaceuticals PLC (”Hikma”)(LSE: HIK)(DIFX: HIK), the multinational pharmaceuticals group, announces that it has agreed to acquire the entire issued share capital of Alkan Pharma (”Alkan”)(the “Company”), an Egyptian pharmaceuticals company, for a cash consideration of $60.5 million (EGP 342 million). The acquisition is scheduled to complete in the second half of 2007, subject to meeting certain regulatory requirements. The acquisition will be funded entirely by debt.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES